Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patterns
Open Access
- 2 December 2025
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 46 (1) , 5
Abstract
Management of ANCA-associated vasculitis (AAV) has significantly improved, yet up to 40% of patients experience relapses, leading to worse long-term outcomes and organ damage. This multicenter cohort study investigated the prognostic value of histopathological patterns in renal AAV for predicting relapse risk and treatment response. We retrospectively analyzed 264 patients with newly diagnosed granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) with renal involvement recruited at four tertiary rheumatology and/or nephrology centers. Baseline clinical data, disease activity scores, and kidney biopsy findings were assessed. Patients were followed for at least twelve months. An overall relapse was defined as renewed disease activity requiring changes in maintenance therapy, initiation of a new induction regimen, or an increase in prednisone dosage > 10 mg/day. A severe relapse required new immunosuppressive induction therapy. After a median follow-up of twelve months the renal domain of the Birmingham Vasculitis Activity Score (BVAS) and its subcategories were evaluated. AAV patients with moderate-to-high (> 25%) interstitial fibrosis and tubular atrophy (IFTA) had a lower risk for both, overall and severe relapses. Severe relapses occurred more frequently in older and male patients. Furthermore, we identified glomerular sclerosis (≥ 50%) to be the strongest predictor for ongoing activity in the renal BVAS domain. Histopathological features do not only help to predict renal recovery and need for dialysis but also to forecast relapse risk and renal BVAS activity. Incorporating these patterns into clinical decision-making could enable more personalized therapy approaches, highlighting the need for prospective validation.Keywords
Funding Information
- Universitätsklinikum RWTH Aachen
This publication has 40 references indexed in Scilit:
- Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohortRheumatology International, 2024
- Distinct pulmonary patterns in ANCA-associated vasculitides: insights from a retrospective single center cohort studyRheumatology International, 2024
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic PolyangiitisArthritis & Rheumatology, 2022
- Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitisJournal Of Nephrology, 2020
- Development and validation of a renal risk score in ANCA-associated glomerulonephritisKidney International, 2018
- Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 439 Cases in a Single Chinese CenterArthritis & Rheumatology, 2014
- Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitidesClinical and Experimental Nephrology, 2013
- Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitisArthritis & Rheumatism, 2011
- Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small‐vessel vasculitis: Comparison of two independent cohortsArthritis & Rheumatism, 2008
- Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Arthritis & Rheumatism, 2005